Potassium iodide

• Description:

  Potassium iodide_x000D_ Catalog number: B2016949_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 25g_x000D_ Molecular Weight or Concentration: 166.00 g/mol_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: RT_x000D_ Keywords: KI_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Yan X, Liu XY, Zhang D, Zhang YD, Li ZH, Liu X, Wu F, Chen GQ. Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis Cell Mol Immunol. 2021 Oct;18(10):2344-2357._x000D_ 2: Huang C, Wang J, Liu H, Huang R, Yan X, Song M, Tan G, Zhi F. Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway BMC Med. 2022 Apr 15;20(1):148._x000D_ 3: Bhattacharya K, Matar W, Tolun AA, Devanapalli B, Thompson S, Dalkeith T, Lichkus K, Tchan M. The use of sodium DL-3-Hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders Orphanet J Rare Dis. 2020 Feb 18;15(1):53._x000D_ 4: Wang J, Huang J, Guo H, Jiang S, Qiao J, Chen X, Qu Z, Cui W, Liu S. Effects of different sodium salts and nitrogen sources on the production of 3-hydroxybutyrate and polyhydroxybutyrate by Burkholderia cepacia Bioresour Bioprocess. 2021 Jul 19;8(1):64._x000D_ 5: Weckx R, Goossens C, Derde S, Pauwels L, Vander Perre S, Van den Bergh G, Langouche L. Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice BMC Pharmacol Toxicol. 2021 Sep 20;22(1):50._x000D_ 6: Ibrahim MI, Alsafadi D, Safi E, Alenazi E, Aboulsoud M, Hussein MA, Alamry KA. Biosynthesized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) as biocompatible microcapsules with extended release for busulfan and montelukast Int J Biol Macromol. 2022 Jul 31;213:728-737._x000D_ 7: Veenvliet ARJ, Garrelfs MR, Udink Ten Cate FEA, Ferdinandusse S, Denis S, Fuchs SA, Schwantje M, Geurtzen R, van Wegberg AMJ, Huigen MCDG, Kluijtmans LAJ, Wanders RJA, Derks TGJ, de Boer L, Houtkooper RH, de Vries MC, van Karnebeek CDM. Neonatal Long-Chain 3-Ketoacyl-CoA Thiolase deficiency: Clinical-biochemical phenotype, sodium-D,L-3-hydroxybutyrate treatment experience and cardiac evaluation using speckle echocardiography Mol Genet Metab Rep. 2022 May 4;31:100873._x000D_ 8: Svart M, Rittig N, Pedersen SB, Jessen N, Møller N. Oral 3-hydroxybutyrate ingestion decreases endogenous glucose production, lipolysis, and hormone-sensitive lipase phosphorylation in adipose tissue in men: a human randomized, controlled, crossover trial Diabet Med. 2021 Feb;38(2):e14385._x000D_ 9: Kim M, Kang J, Yun SI. Alginate-reinforced poly(3-hydroxybutyrate)/ poly(hydroxybutyrate-co-hydroxyvalerate) aerogel monoliths fabricated by phase separation as environmental floating adsorbents Int J Biol Macromol. 2022 Sep 30;217:956-968._x000D_ 10: Cai W, Chong K, Huang Y, Huang C, Yin L. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress Redox Biol. 2024 Feb;69:103010. _x000D_ _x000D_ Products Related to Potassium iodide can be found at Chemicals

• Short Description:

  Catalog Number: B2016949 (25g)

• Weight:

  2.6

• Length:

  3.3

• Width:

  1.2

• Height:

  1.2

• Height :

  1.2